INTRODUCTION: In France, the average steady decline in tuberculosis (TB) incidence close to 5 % per year over the past half-century has been occasionally interrupted by disruptions related to external events. We describe the impact of the COVID-19 pandemic on TB incidence, severity and treatment outcome. METHODS: We analysed the number of TB cases and treatment outcomes reported through the mandatory notification system through 2018-2023. We compared cases reported, notification rates and percentage of cases completing treatment before and after the occurrence of the COVID-19 pandemic. RESULTS: The TB rate and the mean weekly number of cases decreased from 7.6/100,000 to 6.8/100,000 (-10 %) (p=0.96) between 2019 and 2020. This decreasing trend continued, albeit more moderately, in 2021 (-7 %) and 2022 (-2 %). The trend shifted upward in 2023 (7.1/100,000, +15 % compared to 2022). The mean weekly number of reported cases significantly decreased between 2018 (n=97), 2019 (n=97) and 2020 (n= 88) (p